PROPANC BIOPHARMA INC (PPCB) Stock Earnings & Estimates
USA - NASDAQ:PPCB - US74346N7012 - Common Stock
0.8406 USD
-0.06 (-6.81%)
0.8202 USD
-0.02 (-2.43%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | ||||||
| EBITDA YoY % growth | -3.492M | -1.81M 48.16% | -1.989M -9.87% | -1.775M 10.75% | -1.536M 13.48% | |
| EBIT YoY % growth | -3.494M | -1.812M 48.14% | -1.991M -9.86% | -1.777M 10.76% | -1.536M 13.54% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |